HomeAYTU • NASDAQ
add
Aytu Biopharma Inc
Previous close
$2.19
Day range
$2.08 - $2.16
Year range
$0.95 - $2.82
Market cap
21.60M USD
Avg Volume
62.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 13.89M | -16.21% |
Operating expense | 10.69M | -11.88% |
Net income | 1.96M | 33.31% |
Net profit margin | 14.15 | 59.17% |
Earnings per share | -0.09 | — |
EBITDA | -701.00K | -159.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.63M | 62.27% |
Total assets | 124.99M | 7.91% |
Total liabilities | 101.82M | 18.38% |
Total equity | 23.17M | — |
Shares outstanding | 10.19M | — |
Price to book | 0.94 | — |
Return on assets | -3.02% | — |
Return on capital | -8.04% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 1.96M | 33.31% |
Cash from operations | -618.00K | 48.07% |
Cash from investing | — | — |
Cash from financing | 2.30M | 152.03% |
Net change in cash | 1.68M | 1,545.10% |
Free cash flow | -3.51M | -414.95% |
About
Founded
2002
Headquarters
Website
Employees
83
